Biomarker signatures for lyme disease differentiation and methods of use thereof
US10725038B2 · kind B2 · utility
0Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2016 |
| Grant date | Jul 28, 2020 |
| Priority date | — |
| Expiry date | Jan 6, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to methods for the differentiating, diagnosing, and treating Lyme disease in a subject. The methods according to the invention are characterized by the detection of a biomarker signature capable of differentiating Lyme disease from like-symptom diseases, the biomarker signature being comprised of a combination of two or more analytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.